6533b857fe1ef96bd12b42f1
RESEARCH PRODUCT
P0792 : Baseline factors associated with increased SVR rates in 123 treatment-naïve chronic HCV genotype 1 patients treated with a shortened 12-week simeprevir plus pegylated interferon and ribavirin regimen: a multivariate analysis
Christoph SarrazinOliver LenzChristophe MorenoG. Van DoorenAntonio CraxìMaria ButiI. Lonjon-domanecGraham R. FosterTarik AsselahPeter BuggischMichael GschwantlerR RyanM. Schlagsubject
Simeprevirmedicine.medical_specialtyMultivariate analysisHepatologybusiness.industryRibavirinVirologyGastroenterologyTherapy naiveRegimenchemistry.chemical_compoundHcv genotype 1chemistryPegylated interferonInternal medicinemedicinebusinessmedicine.drugyear | journal | country | edition | language |
---|---|---|---|---|
2015-04-01 | Journal of Hepatology |